MDS Pharma Services Wins Two Good Clinical Practice Journal Awards
23 Octobre 2008 - 10:00PM
PR Newswire (US)
Contract research organization honored for excellence in
clinical-trial management KING OF PRUSSIA, PA., Oct. 23
/PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider
of innovative drug-discovery and development solutions, last night
won two awards for superior clinical-trial management at the Good
Clinical Practice Journal (GCPj) Awards event in London. The
contract research organization won top honors for Data Management
Team of the Year and Project Manager of the Year. Additionally, MDS
Pharma Services was a finalist in the Clinical Research Team of the
Year and Most Innovative Patient Recruitment Strategy categories.
"Winning two 2008 GCPj Awards and being a finalist for two more is
a testament to the people, processes and services we deploy on
behalf of our biotech and pharmaceutical clients," said MDS Pharma
Services President David Spaight. "These achievements exemplify our
commitment to client service and high-quality, on-time planning and
execution of clinical research." More than 350 pharmaceutical and
biotech industry executives from around the world attended the GCPj
Awards program. Now in its second year, the GCPj Awards competition
celebrates innovation and excellence in clinical research. The MDS
Pharma Services team in France was recognized as Data Management
Team of the Year for concluding a client project two weeks ahead of
schedule, despite being involved in a number of other clinical
research projects with aggressive timelines. The team's exemplary
performance has resulted in a high degree of client satisfaction,
which has generated repeat business. Dr. Elvira Krauss of MDS
Pharma Services in Germany was honored as Project Manager of the
Year for her exceptional handling of a number of regional and
global clinical-research projects across a range of therapeutic
areas, including vaccines, neurology, immunology, gastroenterology,
cardiovascular and respiratory. About MDS Pharma Services MDS
Pharma Services is committed to delivering quality service on time.
We offer a full spectrum of resources to meet the drug discovery
and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around
the world, we apply advanced scientific and technological expertise
throughout the drug discovery and development process - from lead
optimization, pre-IND research, early clinical research
(bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized
cardiac services. For more information, visit our website at
http://www.mdsps.com/. MDS Pharma Services is a business unit of
MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that
provides market-leading products and services that our customers
need for the development of drugs and diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
5,500 highly skilled people in 29 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: For Media, Charlene McGrady,
(610) 239-7900, ext. 231, ; For Investors, Kim Lee, (416) 675-6777,
ext. 32606,
Copyright